Béla Pikó
Impact in
-
- Cancer Treatment and Pharmacology
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
-
- Breast Cancer Treatment Studies
Papers in
- Oncology 16
- Cancer Treatment and Pharmacology 11
- Colorectal Cancer Treatments and Studies 7
-
- Breast Cancer Treatment Studies 6
- Cancer, Hypoxia, and Metabolism 2
- Co-authors
- Magdolna Dank (6 shared papers)Zsolt Horváth (4 shared papers)Zsuzsanna Kahán (4 shared papers)Katalin Boér (4 shared papers)Jerzy Tujakowski (1 shared paper)Peeter Padrik (1 shared paper)Gunta Purkalne (1 shared paper)Gábor Rubovszky (3 shared papers)
In The Last Decade
Béla Pikó
20 papers receiving 88 citations
Peers
Comparison fields: 5 of 36
- Oncology 59
- Cancer Research 22
- Dermatology 9
- Hepatology 8
- Pulmonary and Respiratory Medicine 19
Countries citing papers authored by Béla Pikó
This map shows the geographic impact of Béla Pikó's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Béla Pikó with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Béla Pikó more than expected).
Fields of papers citing papers by Béla Pikó
This network shows the impact of papers produced by Béla Pikó. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Béla Pikó. The network helps show where Béla Pikó may publish in the future.
Co-authors
The 25 scholars most cited alongside Béla Pikó, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 20 | |
| 2 | 2022 | 14 | |
| 3 | First-line bevacizumab-paclitaxel in 220 patients with metastatic breast cancer: results from the AVAREG study. | 2014 | 11 |
| 4 | 2011 | 9 | |
| 5 | 2013 | 7 | |
| 6 | 2010 | 4 | |
| 7 | 2015 | 3 | |
| 8 | [Systemic therapy of breast cancer: practice guideline]. | 2016 | 3 |
| 9 | [Systemic treatment of breast cancer: professional guideline]. | 2020 | 3 |
| 10 | 2009 | 2 | |
| 11 | 2010 | 2 | |
| 12 | 2008 | 2 | |
| 13 | 2009 | 2 | |
| 14 | [Use of angioneogenesis inhibitor monoclonal antibody following standard therapy in recurrent or progressive glioblastoma multiforme]. | 2012 | 1 |
| 15 | [Principles of radiotherapy of non-small cell lung cancer]. | 2002 | 1 |
| 16 | 2022 | 1 | |
| 17 | 2014 | 1 | |
| 18 | [Extravasation of cytostatic drugs]. | 2011 | 1 |
| 19 | 2022 | 1 | |
| 20 | [Thoughts about thromboembolic events prophylaxis in cancer patients]. | 2011 | 1 |
About Béla Pikó
Béla Pikó is a scholar working on Oncology, Cancer Research, Molecular Biology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 20 papers that have together received 89 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (11 papers), Colorectal Cancer Treatments and Studies (7 papers), Breast Cancer Treatment Studies (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Metabolism, Diabetes, and Cancer (2 papers), Genetic factors in colorectal cancer (2 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Chemotherapy-related skin toxicity (2 papers). The work is most often cited by research in Oncology (59 citations), Cancer Research (22 citations), Dermatology (9 citations), Hepatology (8 citations) and Pulmonary and Respiratory Medicine (19 citations). Béla Pikó has collaborated with scholars based in Hungary, Estonia and Bulgaria. Frequent co-authors include Magdolna Dank, Zsolt Horváth, Zsuzsanna Kahán, Katalin Boér, Jerzy Tujakowski, Peeter Padrik, Gunta Purkalne, Gábor Rubovszky, Zsolt Szabó and László Mangel. Their work appears in journals such as Journal of Clinical Oncology, Breast Cancer, Pathology & Oncology Research, Annals of Oncology and Cancer Management and Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.